European Journal of Molecular & Clinical Medicine

Abstract

Coronavirus-2 (SARS-CoV-2) causes extreme acute respiratory syndrome (SARS) and vascular injury, micro-angiopathy, angiogenesis and widespread thrombosis. The first symptom of the common cold is upper respiratory tract infection. Currently, there is no precise cure for the SARS-CoV-2 infection. COVID-19 reviews numerous prescription drugs used in global economy, which includes antiviral agents, inflammation suppressants, low molecular weight heparins, plasma, and hyperimmune immune globulins. Clinical researchers are using and investigating various ways of handling the virus. This article explores SARS-CoV-2 drug therapy along with other prescription medicines. The article will do the review of the literature done by the authors about the treatment of the coronavirus.